Glow Blend 70mg (BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg)

Glow Blend 70mg is a multi-compound research peptide formulation supplied as a lyophilised vial for controlled analytical and in-vitro studies. This blend combines three research peptides — BPC-157, TB-500, and GHK-Cu — providing researchers the opportunity to examine complex peptide interactions, signalling pathways, and structural behaviour in multi-compound experimental models.
This batch has been tested for purity, confirming suitability for regulated laboratory environments.

---

Key Research Features

• Total content: 70mg

  • BPC-157 — 10mg

  • TB-500 — 10mg

  • GHK-Cu — 50mg

• Lyophilised peptide blend in a sterile laboratory vial

• Batch tested for purity (internal analytical verification)

• Glow Blend is esigned for multi-compound pathway research

• Research-grade production and handling standards

• Stable formulation suitable for in-vitro and analytical studies

• Secure, tamper-evident packaging

---

Common Research Areas

Glow Blend is explored by researchers in laboratory and in-vitro models focusing on:

• Multi-pathway cellular signalling studies

• Regeneration-associated biological pathways

• Cytoskeletal modelling and cell-migration behaviour

• Copper-peptide interactions and structural pathway analysis (GHK-Cu)

• Combined peptide response modelling under controlled conditions

• Stability and degradation behaviour in multi-compound blends

This Glow Blend enables researchers to observe how BPC-157, TB-500, and GHK-Cu behave individually and jointly in controlled experimental contexts. No therapeutic or human application is implied.

---

Research Handling Notes

• Intended strictly for analytical and in-vitro laboratory research

• No preparation, dosing, or usage instructions are provided for Glow Blend

---

Storage & Handling

• Store at 2–8°C in a temperature-regulated environment

• Protect from heat, moisture, and direct light

• Keep sealed until laboratory analysis

• Dispose of materials according to laboratory safety protocols

---

References (For Scientific Literature Context Only)

These publications are provided solely as background scientific literature relevant to GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4 fragment). They do not imply any usage or application of the product.

---

GHK-Cu References

Pickart, L., & Margolina, A. (2018). GHK-Cu: An Overview of Biological Functions and Clinical Applications. Molecules, 23(7), 1417.
URL: https://www.mdpi.com/1420-3049/23/7/1417

Maquart, F. X., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex GHK-Cu. FEBS Letters, 238(2), 343–346.
URL: https://doi.org/10.1016/0014-5793(88)80558-7

Siméon, A., et al. (2000). Copper peptide GHK promotes wound healing and tissue remodeling. Journal of Cellular Biochemistry, 79(3), 423–434.
URL: https://doi.org/10.1002/1097-4644(20001201)79:3<423::AID-JCB110>3.0.CO;2-2

---

BPC-157 References

Sikiric, P., et al. (1999). Stable gastric pentadecapeptide BPC 157: healing effects on gastrointestinal and systemic lesions. Journal of Physiology (Paris), 93(5), 217–226.
URL: https://doi.org/10.1016/S0928-4257(00)88211-3

Seiwerth, S., et al. (2014). BPC 157 and its effects on angiogenesis, nitric oxide pathways, and cytoprotection. Current Pharmaceutical Design, 20(7), 1121–1125.
URL: https://doi.org/10.2174/13816128113199990432

Vukojevic, J., et al. (2020). BPC-157 modulates inflammatory pathways and cellular repair mechanisms in preclinical models. Biomedicine & Pharmacotherapy, 132, 110798.
URL: https://doi.org/10.1016/j.biopha.2020.110798

---

TB-500 (Thymosin Beta-4 Fragment) References

Goldstein, A. L., et al. (2012). Thymosin β4: A multi-functional regenerative peptide. Annals of the New York Academy of Sciences, 1270(1), 84–89.
URL: https://doi.org/10.1111/j.1749-6632.2012.06725.x

Malinda, K. M., et al. (1997). Thymosin β4 stimulates directional migration of endothelial cells. FASEB Journal, 11(6), 474–481.
URL: https://doi.org/10.1096/fasebj.11.6.9194528

Bock-Marquette, I., et al. (2004). Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration in vitro. Nature, 432(7016), 466–472.
URL: https://doi.org/10.1038/nature03000

---

Legal & Safety Notice

This product is supplied strictly for in-vitro laboratory research use only. It is not intended for human consumption, therapeutic use, or any in vivo application.

By purchasing this product, the buyer agrees:

• They are a legal adult (18+ years old).

• The compound will be handled only by qualified professionals in controlled laboratory settings.

• Use is restricted exclusively to lawful in-vitro research purposes.

• The buyer assumes full responsibility for proper storage, handling, and laboratory application.

• No warranties are provided beyond suitability for stated research use.

• Phoenix Biolabs accepts no liability for misuse, misapplication, or unauthorised use.

⚠️ For Research Use Only. Not for Human or Veterinary Use.